Behavioral & Mental Health Software Market Size By Component, By Application By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022

Description

List of Tables

The market for behavioral and mental health software is expected to grow substantially through 2030 owing to the increasing healthcare sector focus toward offering quality care to patients suffering from mental health issues.

The U.S. CDC estimates that more than 50% of the population would be diagnosed with a mental illness at some point in their lifetime. This creates a conducive growth environment for industry expansion.

The industry's projected expansion would further be bolstered by the growing government initiatives and funding towards supporting the adoption of mental health and well-being services. In 2021, the UK government announced n investment of £15 million to promote positive mental health in the most deprived areas in the country.

The behavioral and mental health software industry is segmented in terms of components, applications, end-use, and regional landscape.

In terms of the components, the behavioral and mental health software market is divided into software and services segments. Out of these, the services segment is anticipated to grow at a CAGR of 18.5% over the span of 2022 and 2030. The demand for these services is escalating at an unprecedented pace owing to the growing concerns around mental health issues and rising curve of depression across the world.

Based on the applications spectrum, the market is categorized into financial, clinical, and administrative segments. As per industry analysis, the financial segment was worth $531.8 million in 2021, with future projections anticipating it to accrue substantial gains in the coming years.

With respect to end-use, the behavioral and mental health software market is fragmented into hospitals, community centers, private practices, and others. The private practices segment, amongst these, would expand significantly through the forecast timeframe. Experts speculate that the segment valuation would grow beyond $7.7 billion by 2030. This growth can be credited to the umpteen benefits associated with private practices.

From the regional viewpoint, the Latin America behavioral and mental health software market held an industry share of 3.8% in 2021. The regional market is slated to further develop on account of the rising cognizance regarding mental illness treatment in economies like Brazil, Mexico, Argentina, and others. According to a 2021 study, it was revealed that 87.4% of the people in Mexico lived with a mild mental disorder while 76.2% of those suffered from severe mental disorders like bipolar disorder or schizophrenia.

The Middle East and Africa market landscape is slated to emerge as a lucrative growth hub for the behavioral and mental health software industry. The region is expected to grow at a CAGR of 15.6% through the analysis timeline. Growing cases of mental health disorders and government fundings to promote awareness regarding the same would proliferate the regional progression.

Product Code: 4074

Chapter 1 Methodology

1.1 Market definitions
1.2 Base estimates & working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Behavioral & mental health software industry 36 degree synopsis, 2017-2030
- 2.1.1 Business trends
- 2.1.2 Component trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends

Chapter 3 Behavioral & Mental Health Software Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2017-2030
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing prevalence of mental health disorders
  - 3.3.1.2 Government funding and initiatives toward mental health services
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Data Privacy Concerns
3.4 Growth potential analysis
- 3.4.1 By component
- 3.4.2 By application
- 3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter's analysis
3.7 Competitive landscape, 2021
- 3.7.1 Competitive matrix analysis
3.8 PESTEL analysis

Chapter 4 Behavioral & Mental Health Software Market, By Component

4.1 Key segment trends
4.2 Software
- 4.2.1 Market size, by region, 2017-2030 (USD Million)
- 4.2.2 Web-based
  - 4.2.2.1 Market size, by region, 2017-2030 (USD Million)
- 4.2.3 Cloud-based
  - 4.2.3.1 Market size, by region, 2017-2030 (USD Million)
4.3 Services
- 4.3.1 Market size, by region, 2017-2030 (USD Million)

Chapter 5 Behavioral & Mental Health Software Market, By Application

5.1 Key segment trends
5.2 Clinical
- 5.2.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.2 Electronic Health Record (EHR)
  - 5.2.2.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.3 Health management
  - 5.2.3.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.4 Telehealth
  - 5.2.4.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.5 e- prescribing
  - 5.2.5.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.6 Clinical decision support
  - 5.2.6.1 Market size, by region, 2017-2030 (USD Million)
- 5.2.7 Others
  - 5.2.7.1 Market size, by region, 2017-2030 (USD Million)
5.3 Financial
- 5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Administrative
- 5.4.1 Market size, by region, 2017-2030 (USD Million)

Chapter 6 Behavioral & Mental Health Software Market, By End-use

6.1 Key segment trends
6.2 Hospitals
- 6.2.1 Market size, by region, 2017-2030 (USD Million)
6.3 Community clinics
- 6.3.1 Market size, by region, 2017-2030 (USD Million)
6.4 Private practices
- 6.4.1 Market size, by region, 2017-2030 (USD Million)
6.5 Others
- 6.5.1 Market size, by region, 2017-2030 (USD Million)

Chapter 7 Behavioral & Mental Health Software Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 Market size, by country, 2017-2030 (USD Million)
- 7.2.2 Market size, by component, 2017-2030 (USD Million)
  - 7.2.2.1 Market size, by software, 2017-2030 (USD Million)
- 7.2.3 Market size, by application, 2017-2030 (USD Million)
  - 7.2.3.1 Market size, by clinical, 2017-2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017-2030 (USD Million)
- 7.2.5 U.S.
  - 7.2.5.1 Market size, by component, 2017-2030 (USD Million)
    - 7.2.5.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.2.5.2 Market size, by application, 2017-2030 (USD Million)
    - 7.2.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.2.5.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.2.6 Canada
  - 7.2.6.1 Market size, by component, 2017-2030 (USD Million)
    - 7.2.6.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.2.6.2 Market size, by application, 2017-2030 (USD Million)
    - 7.2.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.2.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.3 Europe
- 7.3.1 Market size, by country, 2017-2030 (USD Million)
- 7.3.2 Market size, by component, 2017-2030 (USD Million)
  - 7.3.2.1 Market size, by software, 2017-2030 (USD Million)
- 7.3.3 Market size, by application, 2017-2030 (USD Million)
  - 7.3.3.1 Market size, by clinical, 2017-2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017-2030 (USD Million)
- 7.3.5 Germany
  - 7.3.5.1 Market size, by component, 2017-2030 (USD Million)
    - 7.3.5.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.3.5.2 Market size, by application, 2017-2030 (USD Million)
    - 7.3.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.3.5.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.3.6 UK
  - 7.3.6.1 Market size, by component, 2017-2030 (USD Million)
    - 7.3.6.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.3.6.2 Market size, by application, 2017-2030 (USD Million)
    - 7.3.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.3.6.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.3.7 France
  - 7.3.7.1 Market size, by component, 2017-2030 (USD Million)
    - 7.3.7.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.3.7.2 Market size, by application, 2017-2030 (USD Million)
    - 7.3.7.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.3.7.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.3.8 Italy
  - 7.3.8.1 Market size, by component, 2017-2030 (USD Million)
    - 7.3.8.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.3.8.2 Market size, by application, 2017-2030 (USD Million)
    - 7.3.8.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.3.8.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.3.9 Spain
  - 7.3.9.1 Market size, by component, 2017-2030 (USD Million)
    - 7.3.9.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.3.9.2 Market size, by application, 2017-2030 (USD Million)
    - 7.3.9.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.3.9.3 Market size, by end-use, 2017-2030 (USD Million)
7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017-2030 (USD Million)
- 7.4.2 Market size, by component, 2017-2030 (USD Million)
  - 7.4.2.1 Market size, by software, 2017-2030 (USD Million)
- 7.4.3 Market size, by application, 2017-2030 (USD Million)
  - 7.4.3.1 Market size, by clinical, 2017-2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017-2030 (USD Million)
- 7.4.5 Japan
  - 7.4.5.1 Market size, by component, 2017-2030 (USD Million)
    - 7.4.5.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.4.5.2 Market size, by application, 2017-2030 (USD Million)
    - 7.4.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.4.5.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.4.6 China
  - 7.4.6.1 Market size, by component, 2017-2030 (USD Million)
    - 7.4.6.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.4.6.2 Market size, by application, 2017-2030 (USD Million)
    - 7.4.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.4.6.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.4.7 India
  - 7.4.7.1 Market size, by component, 2017-2030 (USD Million)
    - 7.4.7.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.4.7.2 Market size, by application, 2017-2030 (USD Million)
    - 7.4.7.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.4.7.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.4.8 Australia
  - 7.4.8.1 Market size, by component, 2017-2030 (USD Million)
    - 7.4.8.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.4.8.2 Market size, by application, 2017-2030 (USD Million)
    - 7.4.8.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.4.8.3 Market size, by end-use, 2017-2030 (USD Million)
7.5 Latin America
- 7.5.1 Market size, by country, 2017-2030 (USD Million)
- 7.5.2 Market size, by component, 2017-2030 (USD Million)
  - 7.5.2.1 Market size, by software, 2017-2030 (USD Million)
- 7.5.3 Market size, by application, 2017-2030 (USD Million)
  - 7.5.3.1 Market size, by clinical, 2017-2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017-2030 (USD Million)
- 7.5.5 Brazil
  - 7.5.5.1 Market size, by component, 2017-2030 (USD Million)
    - 7.5.5.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.5.5.2 Market size, by application, 2017-2030 (USD Million)
    - 7.5.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.5.5.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.5.6 Mexico
  - 7.5.6.1 Market size, by component, 2017-2030 (USD Million)
    - 7.5.6.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.5.6.2 Market size, by application, 2017-2030 (USD Million)
    - 7.5.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.5.6.3 Market size, by end-use, 2017-2030 (USD Million)
7.6 Middle East and Africa
- 7.6.1 Market size, by country, 2017-2030 (USD Million)
- 7.6.2 Market size, by component, 2017-2030 (USD Million)
  - 7.6.2.1 Market size, by software, 2017-2030 (USD Million)
- 7.6.3 Market size, by application, 2017-2030 (USD Million)
  - 7.6.3.1 Market size, by clinical, 2017-2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017-2030 (USD Million)
- 7.6.5 South Africa
  - 7.6.5.1 Market size, by component, 2017-2030 (USD Million)
    - 7.6.5.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.6.5.2 Market size, by application, 2017-2030 (USD Million)
    - 7.6.5.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.6.5.3 Market size, by end-use, 2017-2030 (USD Million)
- 7.6.6 Saudi Arabia
  - 7.6.6.1 Market size, by component, 2017-2030 (USD Million)
    - 7.6.6.1.1 Market size, by software, 2017-2030 (USD Million)
  - 7.6.6.2 Market size, by application, 2017-2030 (USD Million)
    - 7.6.6.2.1 Market size, by clinical, 2017-2030 (USD Million)
  - 7.6.6.3 Market size, by end-use, 2017-2030 (USD Million)

Chapter 8 Company Profiles

8.1 Competitive dashboard, 2021
8.2 Advanced Data Systems Corporation
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 SWOT analysis
8.3 AdvancedMD, Inc.
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
8.4 American Well
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 SWOT analysis
8.5 Netsmart Technologies, Inc.
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
8.6 NXGN Management, LLC
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 SWOT analysis
8.7 Meditab
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
8.8 Therapy Brands.
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 SWOT analysis
8.9 TherapyNotes, LLC.
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
8.10 Qualifacts Systems, Inc.
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
8.11 Valant
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 SWOT analysis
8.12 Teladoc Health Inc
- 8.12.1 Business overview
- 8.12.2 Financial data
- 8.12.3 Product landscape
- 8.12.4 SWOT analysis
8.13 Ontrak Inc
- 8.13.1 Business overview
- 8.13.2 Financial data
- 8.13.3 Product landscape
- 8.13.4 SWOT analysis